跳至主要内容
临床试验/CTRI/2024/08/072297
CTRI/2024/08/072297尚未招募2 期

A retrospective study to short list the different post covid complications in patient attending NIH IPD and OPD and role of homoeopathic medicine in combating post covid respiratory distress

National Institute of Homoeopathy.1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年8月17日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
To assess the changes in intensity and duration of Post Covid respiratory distress after individualised Homoeopathic medication as per the direction of Hahnemann mentioned in Organon of Medicine in §104and §255.

研究概览

简要总结

After getting approval from the ethical committee, the patients will be approached, and educated   about the study and their consent will be obtained.Following preliminary screening for the complaints develops after Covid 19 using specified selection criteria, eligible 50 patients will be recruited in the study.The study is proposed to be conducted both in IPD and OPD of the National Institute of Homoeopathy, Kolkata and the period of the study will be one year. Our study included patients who were having history of COVID-19 (diagnosed by RTPCR or history of having COVID like manifestations). 50 patients of 18-65 years of age will be included in the study.The patients will be interviewed about whether he/she had History of COVID-19 (diagnosed by RTPCR or history of having COVID like manifestations) and the symptoms remain after they have had COVID-19 has to be noted down.Participants fulfilling the inclusion & exclusion criteria shall be included in the study. Case-taking of the participants will be done as per strict Homoeopathic principles and data as per Preliminary details, special questionnaires and scoring according to the Modified Medical Research Council (MCR) dyspnoea scale and MONARCH. Clinical examination or relevant investigations will be done as per requirement.Medicine will be prescribed in Centesimal or Fifty Millesimal potency, maintaining the strict Homoeopathic principles (regarding dose and repetition).The investigator will be the only authority for collection, recording and assessment of the data.Follow up on a regular basis (every 4weeks) for a minimum of 6 months (In case of50 millesimal before repeating the next potency patient shall consult telephonically). After completion of study the result will be represented by using different statistical methods after analysing the results.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • History of COVID-19 (diagnosed by RTPCR or history of having COVID like manifestations).
  • Patient suffering from respiratory distress which develops after Covid19.Age 18-65 years.
  • Both sexes.
  • Ability to understand Bengali or Hindi or English.

排除标准

  • 1.Cases require immediate life support measures.
  • 2.Cases suffering from uncontrolled systemic illness or life-threatening infections or any organ failure.
  • 3.Patients who are too sick for consultation.
  • 4.Unwilling to take part and not giving consent to join the study.
  • 5.Diagnosed cases of unstable mental or psychiatric illness.
  • 6.Pregnant women and lactating mothers 7.Substance abuse and/or dependence.
  • 8.Self-reported immune-compromised state, and 9.Undergoing homoeopathic treatment for any other chronic disease within the last 6 months.

结局指标

主要结局

To assess the changes in intensity and duration of Post Covid respiratory distress after individualised Homoeopathic medication as per the direction of Hahnemann mentioned in Organon of Medicine in §104and §255.

时间窗: Baseline and 6 months

次要结局

  • 1.Modified Medical research Council (MRC) dyspnoea Scale(2.Modified Naranjo Criteria for Homoeopathy (MONARCH))

研究者

发起方
National Institute of Homoeopathy.
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Charusmita Priyadarshani

National Institute of Homoeopathy,Kolkata

研究点 (1)

Loading locations...

相似试验